Agomelatine Production Cost Reports

The report provides a detailed analysis essential for establishing an Agomelatine production plant. It encompasses all critical aspects necessary for Agomelatine production, including the cost of Agomelatine production, Agomelatine plant cost, Agomelatine production costs, and the overall Agomelatine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Agomelatine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Agomelatine is primarily used in the pharmaceutical industry as an antidepressant and anxiolytic agent. It is used in the development and production of psychiatric medications targeting mood disorders such as major depressive disorder and generalized anxiety disorder.

Agomelatine's unique mechanism of action involves agonism at melatonin receptors (MT1 and MT2) to regulate circadian rhythms and antagonism of serotonin 5-HT2C receptors to enhance norepinephrine and dopamine release. This mechanism of action contributes to mood regulation with fewer side effects than many conventional antidepressants.

The global Agomelatine market is driven primarily by the increasing prevalence of depression, sleep disorders, and anxiety worldwide, along with heightened mental health awareness. Its unique mechanism as a melatonergic and serotonergic agent, offering an alternative to traditional antidepressants with fewer side effects, supports its rising adoption. Growth drivers include expanding healthcare infrastructure, favourable regulatory support, and increasing prescriptions in hospital and clinical settings.

Ongoing clinical research, trials, and strategic initiatives by major pharmaceutical companies (e.g., Servier, Novartis) to develop new indications and innovative formulations expanding therapeutic applications, also contribute to the demand. The digitalization of healthcare and integration of technology such as digital mental health platforms, e-prescriptions, and behavioural health apps indirectly enhance adoption and market growth. Factors such as the fluctuations in the costs and availability of the major raw materials directly impact industrial agomelatine procurement.

Raw Material for Agomelatine Production

According to the Agomelatine production plant project report, the raw material for Agomelatine production includes 8-aminonaphthalen-2-ol.

Production Process of Agomelatine

The extensive Agomelatine production cost report consists of the following major industrial production process:

1. Production via chemical synthesis: The production process of Agomelatine involves a series of well-optimized chemical reactions starting from 8-aminonaphthalen-2-ol, which undergoes sequential steps of diazotization-iodination (Sandmeyer reaction), phenol protection via methylation, followed by formylation to yield 7-methoxy-1-naphthaldehyde. This is then subjected to a Henry reaction with nitromethane, catalytic hydrogenation over Pd/C to reduce the nitroalkene to an amine, and final N-acetylation to produce Agomelatine.

Properties of Agomelatine

Agomelatine is a white to off-white crystalline powder with a molecular formula of C15H17NO2 and a molecular weight of 243.3 g/mol. It has a melting point in the range of 108-112 degree Celsius. The compound is sparingly soluble in water and aqueous buffers but is soluble in organic solvents such as ethanol, dimethyl sulfoxide (DMSO), methanol, and dimethyl formamide (DMF). Chemically, Agomelatine is N-[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide, a melatonergic antidepressant structurally similar to melatonin, featuring a naphthalene bioisostere instead of the indole ring system of melatonin. It is stable under refrigeration (0-10 degree Celsius) and heat sensitive. Analytical characterization uses techniques like NMR, mass spectrometry, and HPLC, with purity standards usually above 98%.